Changing the perception of early-phase cancer clinical trials - Cancer Currents Blog

National Cancer Institute sent this bulletin at 11/16/2022 12:37 PM EST

Having trouble viewing this email? View it as a Web page.

Due to a technical issue, the subscriber email for this Cancer Currents story is being sent late. We apologize for any inconvenience.

Changing the Perception of Early-Phase Cancer Clinical Trials: A Conversation with Dr. Naoko Takebe
11/10/2022
	The number of participants in modern phase 1 cancer clinical trials whose cancer responded to the treatment or remained stable has increased substantially. At the same time, treatment-related deaths remained very low, a new NCI study shows. Dr. Naoko Takebe discusses the findings and the importance of phase 1 trials.

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.